Profile
Dr. Nigel J.
Rulewski is Chief Executive Officer at Nextrata Energy, Inc.
Dr. Rulewski was previously employed as Chief Medical Officer by ArQule, Inc., Chief Executive Officer by Innovate Oncology, Inc., Chief Medical Officer & VP-Medical Affairs by Astra USA, Inc., Medical Director by EMD Serono, Inc., Medical Director-International Operations by Fisons Plc, and Senior Vice President by Gardant Pharmaceuticals, Inc. He also served on the board at Avantogen Oncology, Inc.
He received his doctorate degree from the University of London.
Former positions of Nigel John Rulewski
| Companies | Position | End |
|---|---|---|
| AVANTOGEN ONCOLOGY, INC. | Director/Board Member | 2007-01-10 |
Gardant Pharmaceuticals, Inc.
 Gardant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gardant Pharmaceuticals, Inc. develops and commercializes pharmaceutical compounds. It develops network for research, clinical development, and project management and guides them through the clinical development and licensing stages. The company was founded in 2000 and is headquartered in New York, NY | Corporate Officer/Principal | 2006-07-31 |
| Innovate Oncology, Inc. | President | 2006-04-16 |
Nextrata Energy, Inc.
 Nextrata Energy, Inc. Financial ConglomeratesFinance Nextrata Energy, Inc. engages in conducting research and development of pharmaceutical products to fight cancer. The company operates through two subsidiaries: EU Laboratories Limited and Antibody Technologies Inc. Its portfolio consist four products namely: Evo 011 - monoclonal antibody with Evo 022 breast cancer combination therapy; Evo 033 oral reformulation of anti microtubule agent and Evo 044 - stem cell technology which aim to fight cancer. Nextrata Energy was founded in April 1997 and is headquartered in New York. | Chief Executive Officer | - |
Fisons Plc
 Fisons Plc Pharmaceuticals: OtherHealth Technology Fisons Plc Manufactured and supplied ethical and proprietary medicines, veterinary products, laboratory and educational scientific equipment, clinical diagnostic supplies and garden products. The company was headquartered in Ipswichm the United Kingdom. | Corporate Officer/Principal | - |
Training of Nigel John Rulewski
| University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
| Innovate Oncology, Inc. | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Avantogen Oncology, Inc.
 Avantogen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Avantogen Oncology, Inc. operates as a development stage company. It is engaged in the acquisition and development of novel compounds to treat patients with various types of cancer. The company was founded in 1986 and is headquartered in Pasadena, CA. | Health Technology |
Gardant Pharmaceuticals, Inc.
Gardant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gardant Pharmaceuticals, Inc. develops and commercializes pharmaceutical compounds. It develops network for research, clinical development, and project management and guides them through the clinical development and licensing stages. The company was founded in 2000 and is headquartered in New York, NY | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Astra USA, Inc. | |
Fisons Plc
Fisons Plc Pharmaceuticals: OtherHealth Technology Fisons Plc Manufactured and supplied ethical and proprietary medicines, veterinary products, laboratory and educational scientific equipment, clinical diagnostic supplies and garden products. The company was headquartered in Ipswichm the United Kingdom. | Health Technology |
Nextrata Energy, Inc.
Nextrata Energy, Inc. Financial ConglomeratesFinance Nextrata Energy, Inc. engages in conducting research and development of pharmaceutical products to fight cancer. The company operates through two subsidiaries: EU Laboratories Limited and Antibody Technologies Inc. Its portfolio consist four products namely: Evo 011 - monoclonal antibody with Evo 022 breast cancer combination therapy; Evo 033 oral reformulation of anti microtubule agent and Evo 044 - stem cell technology which aim to fight cancer. Nextrata Energy was founded in April 1997 and is headquartered in New York. | Finance |
- Stock Market
- Insiders
- Nigel John Rulewski
